Impact of obesity on walking capacity and cardiovascular parameters in patients with peripheral artery disease: A cross-sectional study

Carregando...
Imagem de Miniatura
Citações na Scopus
8
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
KANEGUSUKU, Helcio
DOMICIANO, Romulo M.
LONGANO, Paulo
RITTI-DIAS, Raphael M.
CORREIA, Marilia A.
Citação
JOURNAL OF VASCULAR NURSING, v.38, n.2, p.66-71, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Patients with peripheral artery disease (PAD) present a high prevalence of obesity and metabolic syndrome, as well as diseases related to cardiovascular dysfunction. However, whether obesity influences walking capacity and cardiovascular function in patients with PAD is poorly understood. Objectives: The objective of this study was to analyze the impact of obesity on walking capacity and cardiovascular parameters in patients with PAD. Design: This is a cross-sectional study. Setting: Patients were recruited from public hospitals of Sao Paulo. Methods: One-hundred two patients with PAD and symptoms of intermittent claudication were recruited and divided into 2 groups according to their body mass index: normal weight (<25 kg/m(2)) and overweight/obese ($25 kg/m(2)). Patients were submitted to objective (6-minute walk test) and subjective measurements of walking capacity (Walking Impairment Questionnaire). In addition, cardiovascular parameters (office blood pressure, resting heart rate, arterial stiffness, vascular function, and heart rate variability) were obtained. Results: The speed domain of the Walking Impairment Questionnaire was lower in the overweight/obese group compared to the normal weight group (32 +/- 20 vs 21 +/- 16, respectively, P < .01). Resting heart rate was higher in overweight/obese patients (61 +/- 10 vs 70 +/- 12, respectively, P < .01). However, no other walking capacity or cardiovascular parameter variables were related to obesity in patients with PAD. Conclusion: Obesity influences resting heart rate and walking speed in patients with PAD.
Palavras-chave
Referências
  1. Addison O, 2017, J GERIATR PHYS THER, V40, P190, DOI 10.1519/JPT.0000000000000096
  2. Bhati P, 2019, CLIN AUTON RES, V29, P75, DOI 10.1007/s10286-018-0558-3
  3. Cai ZJ, 1999, WHO TECH REP SER, V887, P1
  4. Camm AJ, 1996, CIRCULATION, V93, P1043, DOI 10.1016/0044-8486(94)90048-5
  5. Cavalcante BR, 2018, EUR J VASC ENDOVASC, V55, P672, DOI 10.1016/j.ejvs.2018.02.010
  6. Fowkes FGR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.179
  7. Gardner AW, 2018, J VASC SURG, V68, P1126, DOI 10.1016/j.jvs.2017.12.074
  8. Silva RDGE, 2015, J VASC NURS, V33, P21, DOI 10.1016/j.jvn.2014.08.001
  9. Gerage AM, 2019, ARQ BRAS CARDIOL, V113, P410, DOI 10.5935/abc.20190142
  10. Hicks CW, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008644
  11. HIRSCH J, 1991, AM J PHYSIOL, V261, pR1418
  12. Koenig J, 2016, NEUROSCI BIOBEHAV R, V64, P288, DOI 10.1016/j.neubiorev.2016.03.007
  13. Lima AHRA, 2016, EUR J VASC ENDOVASC, V52, P82, DOI 10.1016/j.ejvs.2016.03.029
  14. Lombardi F, 1996, CARDIOVASC RES, V32, P208, DOI 10.1016/0008-6363(96)00116-2
  15. McDermott MM, 2006, J VASC SURG, V43, P1198, DOI 10.1016/j.jvs.2006.02.036
  16. Meng H, 2017, GAIT POSTURE, V53, P145, DOI 10.1016/j.gaitpost.2017.01.019
  17. Montgomery PS, 1998, J AM GERIATR SOC, V46, P706, DOI 10.1111/j.1532-5415.1998.tb03804.x
  18. Ne JYA, 2017, OBES SCI PRACT, V3, P171, DOI 10.1002/osp4.108
  19. Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024
  20. Raval Z, 2012, J VASC SURG, V55, P1015, DOI 10.1016/j.jvs.2011.10.105
  21. Dias RMR, 2009, GERONTOLOGY, V55, P21, DOI 10.1159/000155219
  22. Ritti-Dias RM, 2009, ARQ BRAS CARDIOL, V92, P143, DOI 10.1590/S0066-782X2009000200011
  23. [Anonymous], 2010, Arq. Bras. Cardiol., V95, pI, DOI 10.1590/S0066-782X2010001700001
  24. Spitoni GF, 2017, INT J PSYCHOPHYSIOL, V116, P77, DOI 10.1016/j.ijpsycho.2017.04.001
  25. Strandheim A, 2015, SCAND CARDIOVASC J, V49, P337, DOI 10.3109/14017431.2015.1081273
  26. Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010
  27. Van Bortel LM, 2002, AM J HYPERTENS, V15, P445, DOI 10.1016/S0895-7061(01)02326-3
  28. van Haelst STW, 2018, BRIT J SURG, V105, P252, DOI 10.1002/bjs.10657